Colgate-Palmolive (CL) Tops Q4 EPS by 1c, Comments on Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Colgate-Palmolive Company (CL) PT Lowered to $57 at Macquarie
January 29, 2019 6:52 AM ESTMacquarie analyst Caroline Levy lowered the price target on Colgate-Palmolive Company (NYSE: CL) to $57.00 (from $60.00) while maintaining a Neutral rating. Macquarie cut 2019 EPS estimates to $2.84, 2020 to $3.00 and 2021 to $3.20 (from $2.95, $3.13 and $3.33), for lower ebit margin outlook.
Levy remains cautious on the outlook for the... More
